ADLM Annual Meeting 2024

July 28–August 1, 2024 | Chicago, IL, USA

In-Booth Demonstrations

Our Hemostasis, Acute Care, Autoimmunity, Transfusion and Transplant systems, reagents, data management solutions, and more, will be featured.

To schedule an instrument demonstration or a meeting with our representatives, please contact us. Click the button below and submit the form with your clinical area(s) of interest.

Booth #2813

  • July 30-31: 9:30 AM–5:00 PM CT
  • August 1: 9:30 AM–1:00 PM CT



Industry Workshop

July 30, 2024 | 1:45–2:45 PM CT

Challenges of hemolysis and K+ management

Join this presentation with Dr. Alan Wu and Chris Farnsworth, moderated by Dr. Annie Winkler who will discuss the challenges of hemolysis and K+ management.



Join us at ADLM 2024 to learn about our latest innovations.


Visit Us

Booth #2813

July 30-31 | 9:30 AM-5:00 PM CT
August 1 | 9:30 AM-12:00 PM CT

Our Hemostasis, Acute Care, Autoimmunity, Transfusion and Transplant systems, reagents, digital solutions, and more, will be featured.

Speak with your Werfen rep or complete the form on this page to request an in-booth demonstration.



Virtual Reality Laboratory Experience

See 3D customized layouts of HemoCell® Specialized Lab Automation workcells for Hemostasis Labs of all sizes, shapes, and volumes.

Photo illustration showing the Werfen Virtual Reality experience

AID Flag

Integrated Lab+ solution for Autoimmunity
Visit our booth to see how our comprehensive Autoimmune diagnostics solution can help advance your lab’s capabilities by optimizing efficiency and enhancing clinical decision-making.

Autoimmunity Integrated Lab+ solution showing a lab with Werfen autoimmunity instruments on the work benches

Sign up for Werfen events at ADLM

Acute Care

Attend Our Industry Workshop

Challenges in Pre-Analytical Error Detection: Impact of Hemolysis and Potential Solutions

July 30 | 1:45-2:45 PM CT

Exhibit Hall, Theater 1

What might you be missing in your point-of-care blood gas results?  This workshop will focus on the challenges in pre-analytical error detection, including hemolysis, its prevalence, and impact on potassium and clinical outcomes. Current strategies and a new technology to detect hemolysis to mitigate risk at the point of care will also be discussed.

Workshop Objectives

Describe impact of hemolysis on whole blood potassium results
Identify challenges in current practices to assess in vitro hemolysis
Evaluate a new technology to detect hemolysis at the point of care
Photo of Alan Wu, PhD

Alan Wu, PhD

Professor, Laboratory Medicine, University of California, San Francisco
Co-Core Lab Director, Zuckerberg San Francisco General Hospital
Chief, Clinical Pharmacogenomics Laboratory

Photo of Christopher Farnsworth, PhD

Christopher Farnsworth, PhD

Assoc. Professor, Department of Pathology and Immunology, Washington University School of Medicine
Medical Director Clinical Chemistry POCT, St. Louis, MO

Save your spot!

Powering patient care.

Our passion for innovation—and commitment to help healthcare providers enhance hospital efficiency and patient care around the world—drives us to set new standards in Specialized Diagnostics.

Learn more about our Specialized Diagnostics.

ADLM24 LP NA Rev 00 5.24